Connect with us

NEWS

COVID-19 vaccine mass production ready in Sept – Russia

Published

on

RUSSIAN government says plans are at advanced level for mass production of coronavirus vaccines with several million doses per month capacity taking off September and spanning through the beginning of next year.

  The country are on extensive race for COVID-19 vaccine production amid other contenders for the world’s first coronavirus vaccine production and are targeting the September of this year to hit their target.

  However, the Russian Defence Ministry earlier clarified that tests of the vaccine against coronavirus are being conducted in full compliance with methodological regulations, with no attempts to reduce the duration of the research.

  According to  report, the country is currently said to be planning serial production of the first domestic vaccine developed by the Gamaleya National Research Center of Epidemiology and Microbiology that may be rolled out in September, Russian agency TASS, reports.

  According to Russian Industry and Trade Minister, Denis Manturov, overall production will depend, first and foremost, on the needs of the healthcare system.

  “At the same time, according to preliminary estimates, due to the launch of contract platforms this year we will be able to ensure the production of several hundred thousand doses of vaccine per month with a subsequent increase to several million by the beginning of next year. We will do our best to make sure that these plans are implemented,” he said.

  In addition to that, Russia will also manufacture several million doses of coronavirus vaccines per month by the beginning of next year, the minister added in a media interview.

  Earlier, the country was reported to have kickstarted plans for mass vaccination campaign for the first developed COVID-19 vaccine, touted to be the world’s first such vaccine, and due in October.

  Apart from that, Russia has been gearing up to mass produce another vaccine by November, according to a report.

  Another media report credited to Russia’s Vector State Research Center of Virology and Biotechnology, Director-General Rinat Maksyutov and aired by     Rossiya-1 TV channel, says, the country plans to launch production of a COVID-19 vaccine in November.

  “We expect to start production already in November this year. So, closer to the end of the year and the start of the next year we can talk about switching to vaccination at least for [people] from risk groups with a further switch to massive vaccination,” Maksyutov said, according to the report.

  According to the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 26 coronavirus vaccine options are being developed at 17 research institutions in Russia.

  Meanwhile, Russia reported 5,427 new cases of the novel coronavirus yesterday, bringing its nationwide tally to 850,870, the fourth largest caseload in the world.

Russia’s coronavirus taskforce said 70 people had died over the last 24 hours, pushing the official death toll in the country to 14,128.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending